Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom
Félix Arellano, Alejandro Arana, Charles Wentworth, et al.
Journal of Allergy and Clinical Immunology (2009) Vol. 123, Iss. 5, pp. 1111-1116.e13
Closed Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Guidelines of care for the management of atopic dermatitis
Lawrence F. Eichenfield, Wynnis L. Tom, Sarah L. Chamlin, et al.
Journal of the American Academy of Dermatology (2013) Vol. 70, Iss. 2, pp. 338-351
Open Access | Times Cited: 1084
Guidelines of care for the management of atopic dermatitis
Lawrence F. Eichenfield, Wynnis L. Tom, Timothy G. Berger, et al.
Journal of the American Academy of Dermatology (2014) Vol. 71, Iss. 1, pp. 116-132
Open Access | Times Cited: 1069
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
Patrick M. Brunner, Jonathan I. Silverberg, Emma Guttman‐Yassky, et al.
Journal of Investigative Dermatology (2016) Vol. 137, Iss. 1, pp. 18-25
Open Access | Times Cited: 348
Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis
L. Legendre, Thomas Barnetche, J. Mazereeuw‐Hautier, et al.
Journal of the American Academy of Dermatology (2015) Vol. 72, Iss. 6, pp. 992-1002
Closed Access | Times Cited: 189
Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies
Mark Boguniewicz, Andrew Alexis, Lisa A. Beck, et al.
The Journal of Allergy and Clinical Immunology In Practice (2017) Vol. 5, Iss. 6, pp. 1519-1531
Open Access | Times Cited: 176
Expert consensus on the systemic treatment of atopic dermatitis in special populations
David N. Adam, Melinda Gooderham, Jennifer Beecker, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 6, pp. 1135-1148
Open Access | Times Cited: 49
Suicide-Related Events in Patients Treated with Antiepileptic Drugs
Alejandro Arana, Charles Wentworth, José Luís Ayuso‐Mateos, et al.
New England Journal of Medicine (2010) Vol. 363, Iss. 6, pp. 542-551
Open Access | Times Cited: 205
Topical Calcineurin Inhibitors for Atopic Dermatitis: Review and Treatment Recommendations
Warner Carr
Pediatric Drugs (2013) Vol. 15, Iss. 4, pp. 303-310
Open Access | Times Cited: 161
Topical tacrolimus for atopic dermatitis
Jade Cury‐Martins, Ciro R. Martins, Valéria Aoki, et al.
Cochrane library (2015) Vol. 2016, Iss. 10
Open Access | Times Cited: 152
Long‐term follow‐up of DYT1 dystonia patients treated by deep brain stimulation: An open‐label study
Laura Cif, Xavier Vasques, Victoria González, et al.
Movement Disorders (2010) Vol. 25, Iss. 3, pp. 289-299
Open Access | Times Cited: 147
Topical Calcineurin Inhibitors and Lymphoma Risk: Evidence Update with Implications for Daily Practice
Elaine C. Siegfried, Jennifer C. Jaworski, Adelaide A. Hebert
American Journal of Clinical Dermatology (2013) Vol. 14, Iss. 3, pp. 163-178
Open Access | Times Cited: 130
Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis
Lawrence F. Eichenfield, Robert S. Call, Douglass W. Forsha, et al.
Journal of the American Academy of Dermatology (2017) Vol. 77, Iss. 4, pp. 641-649.e5
Open Access | Times Cited: 124
Clinical practice guidelines for the management of atopic dermatitis 2018
Norito Katoh, Yukihiro Ohya, Masanori Ikeda, et al.
The Journal of Dermatology (2019) Vol. 46, Iss. 12, pp. 1053-1101
Open Access | Times Cited: 116
A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE study)
Jordi Castellsagué, Josephina G. Kuiper, Anton Pottegård, et al.
Clinical Epidemiology (2018) Vol. Volume 10, pp. 299-310
Open Access | Times Cited: 94
English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021
Hidehisa Saeki, Yukihiro Ohya, Junichi Furuta, et al.
The Journal of Dermatology (2022) Vol. 49, Iss. 10
Closed Access | Times Cited: 48
Malignancy risk in patients with atopic dermatitis: a population-based cohort study
Joy Wan, Daniel B. Shin, Maha N. Syed, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 1, pp. 53-61
Closed Access | Times Cited: 22
Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors
Patricia Tennis, Joel M. Gelfand, Kenneth J. Rothman
British Journal of Dermatology (2011) Vol. 165, Iss. 3, pp. 465-473
Closed Access | Times Cited: 104
Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K.
Alejandro Arana, Charles Wentworth, C. Fernández-Vidaurre, et al.
British Journal of Dermatology (2010) Vol. 163, Iss. 5, pp. 1036-1043
Closed Access | Times Cited: 97
Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants
Thomas A. Luger, Mark Boguniewicz, Warner Carr, et al.
Pediatric Allergy and Immunology (2015) Vol. 26, Iss. 4, pp. 306-315
Open Access | Times Cited: 90
Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: Review on safety and benefits
Mamitaro Ohtsuki, Hiroshi Morimoto, Hidemi Nakagawa
The Journal of Dermatology (2018) Vol. 45, Iss. 8, pp. 936-942
Open Access | Times Cited: 74
Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies
LT Zane, Sanjay Chanda, Kurt Jarnagin, et al.
Immunotherapy (2016) Vol. 8, Iss. 8, pp. 853-866
Open Access | Times Cited: 66
Association Between Atopic Eczema and Cancer in England and Denmark
Kathryn E. Mansfield, Sigrún Alba Jóhannesdóttir Schmidt, Bianka Darvalics, et al.
JAMA Dermatology (2020) Vol. 156, Iss. 10, pp. 1086-1086
Open Access | Times Cited: 63
Association Between Topical Calcineurin Inhibitor Use and Risk of Cancer, Including Lymphoma, Keratinocyte Carcinoma, and Melanoma
Megan Lam, Jie Wei Zhu, Mina Tadrous, et al.
JAMA Dermatology (2021) Vol. 157, Iss. 5, pp. 549-549
Open Access | Times Cited: 54
Real-world comorbidities of atopic dermatitis in the pediatric ambulatory population in the United States
Amy H. Huang, Youkyung S. Roh, Nishadh Sutaria, et al.
Journal of the American Academy of Dermatology (2021) Vol. 85, Iss. 4, pp. 893-900
Closed Access | Times Cited: 43
The long‐term safety of topical corticosteroids in atopic dermatitis: A systematic review
Jane Harvey, S. Lax, A. Lowe, et al.
Skin Health and Disease (2023) Vol. 3, Iss. 5
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top